Global Kidney Function Tests

Kidney Function Tests Comprehensive Study by Type (Urine Tests (Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests), Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)), Product (Dipsticks, Reagents, Disposables), End User (Hospitals, Diagnostic Laboratories, Academic Research Laboratories, Others) Players and Region - Global Market Outlook to 2030

Kidney Function Tests Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Kidney Function Tests
The global Kidney Function Tests market is expected to boost in the forecasted period due to the increasing number of Kidneyrelated diseases across the world. Kidneys are among the most vital organs of the human body. kidney function tests are simple blood and urine tests that can help identify problems with kidneys. Additionally, other complications including high blood pressure are contributing to the rising incidence rate and prevalence of chronic kidney disease worldwide. Demand for kidney function tests is mainly triggered by the presence of a large patient population suffering from renal disorders."In 2013, 88.2 percent of all incident cases began renal replacement therapy with hemodialysis, 9.0 percent started with peritoneal dialysis, and 2.6 percent received a preemptive kidney transplant."

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR7.3%


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail of competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Kidney Function Tests market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott (United States), Nova Biomedical (United States), Siemens (Germany), URIT Medical (China), Sysmex (Japan), Roche (Switzerland), Beckman Coulter (United States), ARKRAY (Japan), OPTI Medical (United States) and ACON Laboratories (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are 77 Elektronika (Hungary) and Randox Laboratories (United Kingdom).

Segmentation Overview
AMA Research has segmented the market of Global Kidney Function Tests market by Type (Urine Tests [Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests] and Blood Tests [Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests]) and Region.



On the basis of geography, the market of Kidney Function Tests has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Product, the sub-segment i.e. Dipsticks will boost the Kidney Function Tests market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Kidney Function Tests market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Demand for a High Incidence Rate of Renal Fibrosis and High Demand for Cost-Effectiveness Of Dipstick Testing

Market Growth Drivers:
The Rising Prevalence Of Chronic Kidney Diseases and The Increasing Number of Individuals Suffering from Diabetes

Challenges:
Increased level of both urine and creatinine can indicate the kidney is having some trouble.

Restraints:
The Growing Concern Related to Stringent Regulatory Approvals

Opportunities:
Increasing Healthcare Expenditure in the Developing Countries and Growing Initiatives by the Government for the Awareness and Treatment of Kidney Diseases

Market Leaders and their expansionary development strategies
In March 2024, AstraZeneca announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases.
In October 2018, Siemens Healthineers has teamed up with Israeli start-up Healthy.io to allow patients to test their urine at home by using a smartphone camera that scans a dipstick and sends the results to their doctor.


Key Target Audience
Kidney Function Test Providers, Diagnostic Laboratories, Government Regulatory Bodies, Private Research Organizations, Government Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Urine Tests [Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests]
  • Blood Tests [Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests]
By Product
  • Dipsticks
  • Reagents
  • Disposables

By End User
  • Hospitals
  • Diagnostic Laboratories
  • Academic Research Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Prevalence Of Chronic Kidney Diseases
      • 3.2.2. The Increasing Number of Individuals Suffering from Diabetes
    • 3.3. Market Challenges
      • 3.3.1. Increased level of both urine and creatinine can indicate the kidney is having some trouble.
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for a High Incidence Rate of Renal Fibrosis
      • 3.4.2. High Demand for Cost-Effectiveness Of Dipstick Testing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Kidney Function Tests, by Type, Product, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Kidney Function Tests (Value)
      • 5.2.1. Global Kidney Function Tests by: Type (Value)
        • 5.2.1.1. Urine Tests [Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests]
        • 5.2.1.2. Blood Tests [Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests]
      • 5.2.2. Global Kidney Function Tests by: Product (Value)
        • 5.2.2.1. Dipsticks
        • 5.2.2.2. Reagents
        • 5.2.2.3. Disposables
      • 5.2.3. Global Kidney Function Tests by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diagnostic Laboratories
        • 5.2.3.3. Academic Research Laboratories
        • 5.2.3.4. Others
      • 5.2.4. Global Kidney Function Tests Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Kidney Function Tests (Price)
      • 5.3.1. Global Kidney Function Tests by: Type (Price)
  • 6. Kidney Function Tests: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Nova Biomedical (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. URIT Medical (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sysmex (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Roche (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Beckman Coulter (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ARKRAY (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. OPTI Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ACON Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Kidney Function Tests Sale, by Type, Product, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Kidney Function Tests (Value)
      • 7.2.1. Global Kidney Function Tests by: Type (Value)
        • 7.2.1.1. Urine Tests [Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests]
        • 7.2.1.2. Blood Tests [Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests]
      • 7.2.2. Global Kidney Function Tests by: Product (Value)
        • 7.2.2.1. Dipsticks
        • 7.2.2.2. Reagents
        • 7.2.2.3. Disposables
      • 7.2.3. Global Kidney Function Tests by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diagnostic Laboratories
        • 7.2.3.3. Academic Research Laboratories
        • 7.2.3.4. Others
      • 7.2.4. Global Kidney Function Tests Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Kidney Function Tests (Price)
      • 7.3.1. Global Kidney Function Tests by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Kidney Function Tests: by Type(USD Million)
  • Table 2. Kidney Function Tests Urine Tests [Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests] , by Region USD Million (2018-2023)
  • Table 3. Kidney Function Tests Blood Tests [Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests] , by Region USD Million (2018-2023)
  • Table 4. Kidney Function Tests: by Product(USD Million)
  • Table 5. Kidney Function Tests Dipsticks , by Region USD Million (2018-2023)
  • Table 6. Kidney Function Tests Reagents , by Region USD Million (2018-2023)
  • Table 7. Kidney Function Tests Disposables , by Region USD Million (2018-2023)
  • Table 8. Kidney Function Tests: by End User(USD Million)
  • Table 9. Kidney Function Tests Hospitals , by Region USD Million (2018-2023)
  • Table 10. Kidney Function Tests Diagnostic Laboratories , by Region USD Million (2018-2023)
  • Table 11. Kidney Function Tests Academic Research Laboratories , by Region USD Million (2018-2023)
  • Table 12. Kidney Function Tests Others , by Region USD Million (2018-2023)
  • Table 13. South America Kidney Function Tests, by Country USD Million (2018-2023)
  • Table 14. South America Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 15. South America Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 16. South America Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 17. Brazil Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 18. Brazil Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 19. Brazil Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 20. Argentina Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 21. Argentina Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 22. Argentina Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 23. Rest of South America Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 25. Rest of South America Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 26. Asia Pacific Kidney Function Tests, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 29. Asia Pacific Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 30. China Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 31. China Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 32. China Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 33. Japan Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 34. Japan Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 35. Japan Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 36. India Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 37. India Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 38. India Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 39. South Korea Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 40. South Korea Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 41. South Korea Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 42. Taiwan Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 43. Taiwan Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 44. Taiwan Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 45. Australia Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 46. Australia Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 47. Australia Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 51. Europe Kidney Function Tests, by Country USD Million (2018-2023)
  • Table 52. Europe Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 53. Europe Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 54. Europe Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 55. Germany Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 56. Germany Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 57. Germany Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 58. France Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 59. France Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 60. France Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 61. Italy Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 62. Italy Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 63. Italy Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 64. United Kingdom Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 65. United Kingdom Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 66. United Kingdom Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 67. Netherlands Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 68. Netherlands Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 69. Netherlands Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 70. Rest of Europe Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 71. Rest of Europe Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 72. Rest of Europe Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 73. MEA Kidney Function Tests, by Country USD Million (2018-2023)
  • Table 74. MEA Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 75. MEA Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 76. MEA Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 77. Middle East Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 78. Middle East Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 79. Middle East Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 80. Africa Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 81. Africa Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 82. Africa Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 83. North America Kidney Function Tests, by Country USD Million (2018-2023)
  • Table 84. North America Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 85. North America Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 86. North America Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 87. United States Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 88. United States Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 89. United States Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 90. Canada Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 91. Canada Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 92. Canada Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 93. Mexico Kidney Function Tests, by Type USD Million (2018-2023)
  • Table 94. Mexico Kidney Function Tests, by Product USD Million (2018-2023)
  • Table 95. Mexico Kidney Function Tests, by End User USD Million (2018-2023)
  • Table 96. Kidney Function Tests: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Kidney Function Tests: by Type(USD Million)
  • Table 108. Kidney Function Tests Urine Tests [Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests] , by Region USD Million (2025-2030)
  • Table 109. Kidney Function Tests Blood Tests [Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests] , by Region USD Million (2025-2030)
  • Table 110. Kidney Function Tests: by Product(USD Million)
  • Table 111. Kidney Function Tests Dipsticks , by Region USD Million (2025-2030)
  • Table 112. Kidney Function Tests Reagents , by Region USD Million (2025-2030)
  • Table 113. Kidney Function Tests Disposables , by Region USD Million (2025-2030)
  • Table 114. Kidney Function Tests: by End User(USD Million)
  • Table 115. Kidney Function Tests Hospitals , by Region USD Million (2025-2030)
  • Table 116. Kidney Function Tests Diagnostic Laboratories , by Region USD Million (2025-2030)
  • Table 117. Kidney Function Tests Academic Research Laboratories , by Region USD Million (2025-2030)
  • Table 118. Kidney Function Tests Others , by Region USD Million (2025-2030)
  • Table 119. South America Kidney Function Tests, by Country USD Million (2025-2030)
  • Table 120. South America Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 121. South America Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 122. South America Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 123. Brazil Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 124. Brazil Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 125. Brazil Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 126. Argentina Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 127. Argentina Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 128. Argentina Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 129. Rest of South America Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 130. Rest of South America Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 131. Rest of South America Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 132. Asia Pacific Kidney Function Tests, by Country USD Million (2025-2030)
  • Table 133. Asia Pacific Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 134. Asia Pacific Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 135. Asia Pacific Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 136. China Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 137. China Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 138. China Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 139. Japan Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 140. Japan Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 141. Japan Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 142. India Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 143. India Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 144. India Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 145. South Korea Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 146. South Korea Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 147. South Korea Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 148. Taiwan Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 149. Taiwan Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 150. Taiwan Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 151. Australia Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 152. Australia Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 153. Australia Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 154. Rest of Asia-Pacific Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 155. Rest of Asia-Pacific Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 157. Europe Kidney Function Tests, by Country USD Million (2025-2030)
  • Table 158. Europe Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 159. Europe Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 160. Europe Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 161. Germany Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 162. Germany Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 163. Germany Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 164. France Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 165. France Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 166. France Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 167. Italy Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 168. Italy Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 169. Italy Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 170. United Kingdom Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 171. United Kingdom Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 172. United Kingdom Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 173. Netherlands Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 174. Netherlands Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 175. Netherlands Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 176. Rest of Europe Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 177. Rest of Europe Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 178. Rest of Europe Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 179. MEA Kidney Function Tests, by Country USD Million (2025-2030)
  • Table 180. MEA Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 181. MEA Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 182. MEA Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 183. Middle East Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 184. Middle East Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 185. Middle East Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 186. Africa Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 187. Africa Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 188. Africa Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 189. North America Kidney Function Tests, by Country USD Million (2025-2030)
  • Table 190. North America Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 191. North America Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 192. North America Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 193. United States Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 194. United States Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 195. United States Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 196. Canada Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 197. Canada Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 198. Canada Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 199. Mexico Kidney Function Tests, by Type USD Million (2025-2030)
  • Table 200. Mexico Kidney Function Tests, by Product USD Million (2025-2030)
  • Table 201. Mexico Kidney Function Tests, by End User USD Million (2025-2030)
  • Table 202. Kidney Function Tests: by Type(USD/Units)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Kidney Function Tests: by Type USD Million (2018-2023)
  • Figure 5. Global Kidney Function Tests: by Product USD Million (2018-2023)
  • Figure 6. Global Kidney Function Tests: by End User USD Million (2018-2023)
  • Figure 7. South America Kidney Function Tests Share (%), by Country
  • Figure 8. Asia Pacific Kidney Function Tests Share (%), by Country
  • Figure 9. Europe Kidney Function Tests Share (%), by Country
  • Figure 10. MEA Kidney Function Tests Share (%), by Country
  • Figure 11. North America Kidney Function Tests Share (%), by Country
  • Figure 12. Global Kidney Function Tests: by Type USD/Units (2018-2023)
  • Figure 13. Global Kidney Function Tests share by Players 2023 (%)
  • Figure 14. Global Kidney Function Tests share by Players (Top 3) 2023(%)
  • Figure 15. Global Kidney Function Tests share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott (United States) Revenue: by Geography 2023
  • Figure 19. Nova Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 20. Nova Biomedical (United States) Revenue: by Geography 2023
  • Figure 21. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Siemens (Germany) Revenue: by Geography 2023
  • Figure 23. URIT Medical (China) Revenue, Net Income and Gross profit
  • Figure 24. URIT Medical (China) Revenue: by Geography 2023
  • Figure 25. Sysmex (Japan) Revenue, Net Income and Gross profit
  • Figure 26. Sysmex (Japan) Revenue: by Geography 2023
  • Figure 27. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Roche (Switzerland) Revenue: by Geography 2023
  • Figure 29. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 30. Beckman Coulter (United States) Revenue: by Geography 2023
  • Figure 31. ARKRAY (Japan) Revenue, Net Income and Gross profit
  • Figure 32. ARKRAY (Japan) Revenue: by Geography 2023
  • Figure 33. OPTI Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. OPTI Medical (United States) Revenue: by Geography 2023
  • Figure 35. ACON Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 36. ACON Laboratories (United States) Revenue: by Geography 2023
  • Figure 37. Global Kidney Function Tests: by Type USD Million (2025-2030)
  • Figure 38. Global Kidney Function Tests: by Product USD Million (2025-2030)
  • Figure 39. Global Kidney Function Tests: by End User USD Million (2025-2030)
  • Figure 40. South America Kidney Function Tests Share (%), by Country
  • Figure 41. Asia Pacific Kidney Function Tests Share (%), by Country
  • Figure 42. Europe Kidney Function Tests Share (%), by Country
  • Figure 43. MEA Kidney Function Tests Share (%), by Country
  • Figure 44. North America Kidney Function Tests Share (%), by Country
  • Figure 45. Global Kidney Function Tests: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Abbott (United States)
  • Nova Biomedical (United States)
  • Siemens (Germany)
  • URIT Medical (China)
  • Sysmex (Japan)
  • Roche (Switzerland)
  • Beckman Coulter (United States)
  • ARKRAY (Japan)
  • OPTI Medical (United States)
  • ACON Laboratories (United States)
Additional players considered in the study are as follows:
77 Elektronika (Hungary) , Randox Laboratories (United Kingdom)
Select User Access Type

Key Highlights of Report


Mar 2024 230 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Kidney Function Tests Quantitative research analysis
Global Kidney Function Tests Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott (United States), Nova Biomedical (United States), Siemens (Germany), URIT Medical (China), Sysmex (Japan), Roche (Switzerland), Beckman Coulter (United States), ARKRAY (Japan), OPTI Medical (United States) and ACON Laboratories (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Demand for a High Incidence Rate of Renal Fibrosis " is seen as one of major influencing trends for Kidney Function Tests Market during projected period 2023-2030.
The Kidney Function Tests market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Kidney Function Tests Report?

Have a Query? Click Here

Other Related Reports

Breast Imaging Technology Comprehensive Study by Type (Ionizing Breast Imaging Technologies (Mammography (FFDM, Digital & 3D Mammography), PEM, PET-CT, MBI/BSGI, CBCT), Non-ionizing Breast Imaging Te...
$ 3750
Stroke Post Processing Software Comprehensive Study by Type (Ischemic Stroke, Hemorrhagic Stroke, Others), Installation (Desktops, Mobile Phones, Tablets), End-Use (Diagnostic Centers, Hospitals, Amb...
$ 3450
Heart-on-a-chip Comprehensive Study by Type (Children Heart-on-a-chip, Adult Heart-on-a-chip), Application (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other End Users) ...
$ 3500
Nuclear Medicine Preclinical Imaging Equipment Comprehensive Study by Application (Oncology, Cardiology, Neurology, Thyroid), Diagnostics (SPECT (Standalone, SPECT/CT System, SPECT/MRI System), PET (...
$ 3750
Smart Home Healthcare Comprehensive Study by Application (Fall Prevention and Detection, Health Status Monitoring, Nutrition and Diet Monitoring, Memory Aids, Others), Technology (Wired, Wireless), S...
$ 3450
Preclinical Molecular Imaging Comprehensive Study by Type (Equipment/Device, Reagents and Imaging Agents, Service), Equipment Type (MRI, MPI, Ultrasound, Preclinical Nuclear Imaging Systems (SPECT, ...
$ 3750